Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |